Meeting
2020 Gastrointestinal Cancers Symposium
The role of immunotherapy on the survival of pancreatic cancer patients.
Authors
Saber Ali Amin
University of Nebraska Medical Center, Omaha, NE
Saber Ali Amin , Michael Baine , Jane L. Meza , Chi Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 714)
Abstract #
714
Poster Bd #
L3
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes.
First Author: Lilly Gu
Poster
2021 ASCO Annual Meeting
The impact of multimodality therapies in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program (TSP) experience.
First Author: Olga Vornicova
Poster
2020 Gastrointestinal Cancers Symposium
Long-term outcome after combined carbon-ion radiotherapy and chemotherapy for locally advanced pancreatic cancer.
First Author: Makoto Shinoto